The Taiwan Fund (TWN) Stock Price, News & Analysis

Company Overview

The Taiwan Fund, Inc. is a closed-ended equity mutual fund launched and managed by Nomura Asset Management U.S.A. Inc. It invests in the public equity markets of Taiwan. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental analysis focusing on such factors as overall growth prospects, competitive position in the respective industry, technology, research, and development, productivity, labor costs, raw material costs and sources, profit margins, return on investment, capital resources, government regulation, and management to create its portfolio. The fund benchmarks the performance of its portfolio against the TAIEX Total Return Index. The Taiwan Fund, Inc. was formed on December 23, 1986 and is domiciled in the United States.

Key Stats

• Today's Range: $30.02 to $30.76
• 50-Day Range: $27.85 to $39.06
• 52-Week Range: $26.45 to $47.24
• Volume: 13,117 shs
• Average Volume: 22,352 shs
• Market Capitalization: $193.51 million
• P/E Ratio: N/A
• Dividend Yield: 24.42%
• Price Target: N/A
• Consensus Rating: N/A

TWN Stock Analysis - Frequently Asked Questions

How have TWN shares performed this year?

The Taiwan Fund's stock was trading at $38.65 on January 1st, 2025. Since then, TWN stock has decreased by 21.7% and is now trading at $30.2640.
View the best growth stocks for 2025 here.

How do I buy shares of The Taiwan Fund?

Shares of TWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of The Taiwan Fund own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Taiwan Fund investors own include Taiwan Semiconductor Manufacturing (TSM), Genco Shipping & Trading (GNK), International Business Machines (IBM), Vulcan Materials (VMC), AbbVie (ABBV), CVS Health (CVS) and Gilead Sciences (GILD).

Company Calendar

• Today: 4/18/2025
• Fiscal Year End: 8/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Private households
• Sub-Industry: Financial Services
• Current Symbol: NYSE:TWN
• CIK: 804123
• Web: www.thetaiwanfund.com
• Phone: (800) 426-5523
• Fax: 886-2-2325-5748
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $99.70 million
• Price / Sales: 1.94
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,394,000
• Free Float: 8,342,000
• Market Cap: $193.51 million
• Optionable: Not Optionable
• Beta: 1.11